Page last updated: 2024-10-25

cilostazol and Cardiomyopathies

cilostazol has been researched along with Cardiomyopathies in 1 studies

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koh, JS1
Yi, CO1
Heo, RW1
Ahn, JW1
Park, JR1
Lee, JE1
Kim, JH1
Hwang, JY1
Roh, GS1

Other Studies

1 other study available for cilostazol and Cardiomyopathies

ArticleYear
Protective effect of cilostazol against doxorubicin-induced cardiomyopathy in mice.
    Free radical biology & medicine, 2015, Volume: 89

    Topics: Animals; Antibiotics, Antineoplastic; Blotting, Western; Cardiomyopathies; Cilostazol; Doxorubicin;

2015